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Increased risk of end stage renal disease (ESRD) and death in Norwegian living kidney
donors has been reported, most of the donors were related to the recipient. The present
study investigates risk of death in first degree relatives of ESRD patients.
Methods
The Norwegian Population Registry, The Norwegian Cause of Death Registry and the Nor-
wegian Renal Registry were linked. All citizens born in Norway, alive in 1960 and with at
least one registered first degree relative were included; individuals who died during the first
year of life were excluded. A cohort-design was used, ESRD in a first degree relative was
the main exposure variable and death and causes of death were the main outcome vari-
ables. Cox regression statistics were used to investigate mortality risks.
Results
5 130 600 individuals were included, 27 508 had at least one first degree relative with
ESRD. 828 022 died during follow-up, of whom 4105 had a first degree relative with ESRD.
Adjusted hazard ratio (aHR) for death was 1.13 (1.09–1.16) in individuals with a relative
with ESRD compared to those without a relative with ESRD. Excluding known hereditary
renal disease, aHR decreased to 1.12 (1.09–1.15). Cardiovascular death aHR was 1.15
(1.10–1.21), of which cerebrovascular death 1.34 (1.22–1.50). aHR for death due to non-
hereditary renal/ureteric disease was 2.29 (1.81–2.91) with renal failure 1.80 (1.26–2.56)
and glomerular disease 5.69 (3.88–8.34) as main contributors. Diabetes mellitus death
aHR was 1.68 (1.35–2.10). Absolute mortality risks increased most for the oldest cohorts
with excess mortality of 148 per 100.000 person years for the cohort born 1920–39 and 218
for the cohort born 1900–1919.
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Conclusions
ESRD in first degree relatives was associated with increased hazard ratio for death. Death
due to cardiovascular disease, renal disease and diabetes mellitus increased the most.
Introduction
A registry based study from Utah has previously described increased risk of dying with end
stage renal disease (ESRD) or chronic kidney disease (CKD) in first degree relatives of ESRD
patients. Relative risk of death with ESRD was 10.1 and relative risk of death with CKDwas
3.89[1]. We have previously shown that first degree relatives of ESRD patients are at increased
risk of developing ESRD, arguing for hereditary contributions to ESRD risk[2]. Chronic kidney
disease and ESRD are well known risk factors for cardiovascular disease[3, 4], and absolute risk
of death has been found to increase exponentially with declining kidney function[5]. A case
control study showed that relative risk of cardiovascular death in first degree relatives of ESRD
patients was 1.10 [6], with acute myocardial infarction and heart failure as the main
contributors.
Increased risk of all cause death and cardiovascular death has been reported in a cohort of
1900 Norwegian living kidney donors, most of the donors were first degree relatives of the
recipient[7]. A loss of three years of life compared to matched healthy controls was found in
the same cohort[7]. The cause of this observation is uncertain, but may be related to reduced
kidney function after nephrectomy, or genetic or environmental factors shared with the kidney
recipient. Few studies have however investigated cause-specificmortality at a population-level
in relatives of patients with ESRD, and more data are needed.
In the present study we link data from the Norwegian Population Registry, Norwegian
Nephrology Registry and Norwegian Cause of Death Registry, and analyze whether first degree
relatives of patients with ESRD have increasedmortality. Risk of death was further analyzed
according to cause of death as well as cause of ESRD in the relative.
Materials and Methods
Approval from the Regional Ethics Committee was obtained before the Norwegian Population
Registry, the Norwegian Cause of Death Registry and the Norwegian Renal Registrywere
linked to generate a de-identified dataset.
The Norwegian Cause of Death Registrywas established in 1951, registering data on causes
of death using the International Classification of Diseases (ICD). Primary and contributing
causes of death are reported on a death certificate by the responsible physician. ICD versions
8–10 were used, version 8 for 1969–1985, version 9 for 1986–1995 and version 10 for 1996–
2008. The attending physician gives the mandatory primary cause of death on the death certifi-
cate. Cause of death is later re-evaluated at the National Cause of Death Registry, using interna-
tional standards. In addition to the primary cause of death, up to 3 contributing causes could
have been recorded from 1969 to 1995, and up to 6 contributing causes from 1996 onwards.
Data were available from January 1969 through 2008. The Norwegian Population Registrywas
established in 1960, identifying all Norwegian citizens and non-national residents through an
11-digit personal identification number. Registration of parental information for individuals
residing with their parents started in 1970, and for this study parental information was avail-
able for most individuals born 1953 or later. The Norwegian Renal Registryhas since 1980 reg-
istered all individuals in Norway with end-stage renal disease (ESRD), defined as either
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chronic dialysis treatment or renal transplantation. The cause of ESRD was reported by the
treating physician, using the old European Renal Association-European Dialysis and Trans-
plant Association classification[8]. Data were available through June 2009.
First degree relatives, defined as parents, siblings (defined as having the same mother and
father), or children, were identified based on data from the Norwegian Population Registry.
Individuals who were born in Norway and were alive in 1960 were eligible for inclusion. Indi-
viduals who died during the first year of life or with no reported first degree relatives were
excluded. Data from the registries were linked using the national 11-digit identification
number.
Explanatory Variables
Development of ESRD in a first degree relative before July 2009 was the main exposure vari-
able. A person with ESRD could be registered as a first degree relative of several included
individuals.
In adjusted analyses, gender, birth year and number of recorded first degree relatives were
used. Numbers of relatives were grouped as 1–2, 3–4, 5–7 and 8 or more and were included in
the adjusted analysis as a continuous variable.
Outcome Variables
The main outcome was death. Surviving individuals were followed until June 2009. Secondary
outcomes were different primary causes of death. S1 Table describes the categories of cause of
death that have been used in the present publication, and their ICD codes. Fig 1 describes
inclusion, exposure and outcomes in a flowchart.
Statistical Analyses
We applied a cohort design with ESRD in a first degree relative as the main exposure variable
and death, or cause of death, as the outcome variables. Relative risk of death was analyzed by
Cox regression analyses with age as the time variable. Analyses were adjusted by including the
described variables as covariates in the Cox regression model. As cause of death was not avail-
able before 1969, the statistical analyses of cause of death were left truncated. Consequently the
counting process of proportional hazards (Cox regression) was applied[9], whereby individuals
are not included in the analysis until an event can be registered. Failure curves are presented as
figures.Multivariate Cox proportional-hazards modeling was used to adjust for birth year,
number of relatives and gender. Overall and cause-specificmortality rates were calculated as
number of deaths per 100.000 person-years at risk; only follow-up years after 1969 were
included in these calculations. These results are presented separately for birth year cohorts and
increase in absolute mortality risk between study groups were calculated as the absolute differ-
ence between groups.
If not otherwise stated, means ± standard deviations or estimates (95% confidence intervals
[95% CIs]) are given. The analyses were performedwith the statistical package STATA MP edi-
tion 11.1 (StataCorp).
Results
The study included 5 130 600 individuals, of whom 27 508 had at least one first degree relative
with ESRD. During follow-up 828 022 individuals died, 4105 of these had a first degree relative
with ESRD. The most common causes of death were cardiovascular disease, cancer and pulmo-
nary disease (S1 Table). Deceased individuals in the cohort were more often men, and had
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fewer recorded first degree relatives than individuals who did not die during follow-up
(Table 1).
Having a first degree relative with ESRD was significantly associated with increased risk of
death. Hazard ratio (HR) for death was 1.07 (1.04–1.11) as compared to individuals without a
first degree relative with ESRD (Table 2). When adjusted for gender, birth year and number of
first degree relatives, HR increased to 1.13 (1.09–1.16). HR was smaller, but still highly statisti-
cally significant, after excluding individuals who had relatives with known hereditary renal dis-
ease; in these analyses, HR was 1.06 (1.02–1.09) in unadjusted analyses and 1.12 (1.08–1.16) in
adjusted analyses. When individuals who developed ESRD and individuals with a relative with
known hereditary renal disease were excluded, HR was 1.05 (1.02–1.09) and adjusted HR
(aHR) 1.11 (1.08–1.15).
Hazard ratios for the most important causes of death were analyzed (Table 2), the selection
was based on the three most common causes of death and causes of death known to be related
to kidney disease. In these analyses, HR was significantly increased for cardiovascular death
(1.11 (1.06–1.16)), death due to diseases of the kidney and ureter (HR 2.18 (1.72–2.77)) and
death due to diabetes mellitus (HR 1.59 (1.28–1.98)). HR for death due to cancer was< 1 in
unadjusted analyzes, and not significantly raised in adjusted analyses. These results are sum-
marized in a Forest plot (Fig 2).
Hazard ratios for subgroups of cardiovascular death were further analyzed in Table 3, cere-
brovascular death was associated with the highest adjusted HR 1.34 (1.22–1.47), aHR for death
due to ischemic heart disease was 1.11 (1.03–1.18), aHR for death due to other non-valvular
Fig 1. Overview of inclusion and exclusion criteria, exposure and outcomes.
doi:10.1371/journal.pone.0165026.g001
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Table 1. Characteristics of the population.
Characteristics Total cohort Born 1953 or later
Alive Deceased Alive Deceased
N (%) 4 302 578 (83.9%) 828 022 (16.1%) 3 165 259 (98.4%) 51 897 (1.6%)
N (%) with first degree relative with ESRD 23 403 (0.5%) 4105 (0.5%) * 17 645 (0.6%) 507 (1.0%) *
Gender (% male) 2 153 680 (50.1%) 484 048 (58.5%) * 1 615 444 (51.0%) 35 331 (68.1%) *
Mean (SD) birth year 1969 (±23.1) 1923 (±15.8) * 1980 (±16.0) 1965 (±10.4) *
Mean (SD) no. of recorded relatives 4.3 (2.0) 2.5 (1.6) * 4.6 (2.0) 4.5 (1.9) a
Number of recorded relatives
N (%) with 1–2 recorded relatives 721 164 (16.8%) 515 861 (62.3%) * 305 033 (9.6%) 5 199 (10.0%) *
N (%) with 3–4 recorded relatives 1 900 922 (44.2%) 225 287 (27.2%) * 1 487 660 (47.0%) 23 807 (45.9%) a
N (%) with 5–7 recorded relatives 1 366 179 (31.8%) 74 205 (9.0%) * 1 120 839 (35.4%) 19 259 (37.1%) *
N (%) with 8 or more recorded relatives 314 313 (7.3%) 12 669 (1.5%) * 251 727 (8.0%) 3 596 (6.9%) *
N (%) with recorded parents 3 491 244 (81.1%) 106 416 (12.9%) * 3 119 781 (98.6%) 50 245 (96.8%) *
N (%) with recorded siblings 2 999 423 (69.7%) 80 473 (9.7) * 2 721 346 (86.0%) 44 279 (85.3%) *
N (%) with recorded children 2 445 381 (56.8%) 745 112 (90.0) * 1 390 979 (44.0%) 18 125 (34.9%) *
Year of birth
N (%) born 1900–1929 216 099 (5.0) 616 927 (74.5) NA NA
N (%) born 1930–1949 756 427 (17.6) 148 408 (17.9) NA NA
N (%) born 1950–1969 1 195 273 (27.8) 47 496 (5.7) 1 030 480 (32.6) 36 706 (70.7)
N (%) born 1970–2009 2 134 779 (49.6) 15 191 (1.8) 2 134 779 (67.4) 15 191 (29.3)
* = p <0.001
a = not significant
doi:10.1371/journal.pone.0165026.t001







Hazard ratio p-value Adjusted hazard
ratio*
p-value
Death, all causes No 5 103 092 828 022 1.0 (ref) 1.0 (ref)
Yes 27 508 4105 1.07 (1.04–
1.11)
<0.001 1.13 (1.09–1.16) <0.001
Death due to cardiovascular disease No 5 103 092 338 310 1.0 (ref) 1.0 (ref)
Yes 27 508 1 651 1.11 (1.06–
1.16)
<0.001 1.15 (1.10–1.21) <0.001
Death due to diseases of the kidneys and ureters No 5 103 092 7 095 1.0 (ref) 1.0 (ref)
Yes 27 508 69 2.18 (1.72–
2.77)
<0.001 2.35 (1.85–2.99) <0.001
Death due to diabetes mellitus No 5 103 092 10 973 1.0 (ref) 1.0 (ref)
Yes 27 508 81 1.59 (1.28–
1.98)
<0.001 1.68 (1.35–2.10) <0.001
Death due to chronic lower respiratory tract
diseases and respiratory tract infections
No 5 103 092 27 988 1.0 (ref) 1.0 (ref)
Yes 27 508 114 0.94 (0.79–
1.14)
0.54 1.00 (0.83–1.20) 0.96
Death due to cancer No 5 103 092 223 122 1.0 (ref) 1.0 (ref)
Yes 27 508 951 0.93 (0.87–
0.99)
0.03 0.98 (0.91–1.04) 0.45
*Adjusted for sex, birth year and no. of relatives. Individuals with diabetes mellitus as a contributing cause of death were excluded in adjusted analyses.
doi:10.1371/journal.pone.0165026.t002
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cardiovascular disease was 1.16 (1.02–1.34) and aHR for death due to hypertension was 1.30
(0.97–1.76). Hazard ratios for death due to subgroups of diseases of the kidneys and ureters are
listed in Table 4. Diseases of the kidneys and ureters, hereditary or non-hereditary, were listed
as the primary cause of death in 123 individuals with a first degree relative with ESRD, aHR
was 3.95 (3.30–4.72). After exclusion of known congenital or hereditary causes, aHR decreased
to 2.29 (1.81–2.91). aHR for death due to acute or chronic renal failure was 1.80 (1.26–2.56),
and aHR for death due to glomerular disease was 5.69 (3.88–8.34).
Fig 2. Adjusted risk of death according to different causes of death in individuals with first degree
relatives with ESRD.
doi:10.1371/journal.pone.0165026.g002







Hazard ratio p-value Adjusted hazard
ratio*
p-value
Death due to cerebrovascular disease No 5 103 092 77 000 1.0 (ref)
Yes 27 508 435 1.29 (1.17–
1.41)
<0.001 1.34 (1.22–1.47) <0.001
Death due to ischemic heart disease No 5 103 092 180 801 1.0 (ref)
Yes 27 508 828 1.04 (0.97–
1.11)
0.26 1.11 (1.03–1.18) 0.004
Death due to other cardiovascular
disease, non valvular
No 5 103 092 40 586 1.0 (ref)
Yes 27 508 206 1.14 (0.99–
1.31)
0.06 1.16 (1.02–1.34) 0.03
Death due to non-rheumatic valvular
disease
No 5 103 092 8057 1.0 (ref)
Yes 27 508 31 0.88 (0.62–
1.26)
0.49 0.90 (0.64–1.29) 0.58
Death due to hypertension No 5 103 092 8027 1.0 (ref)
Yes 27 508 43 1.23 (0.91–
1.66)
0.18 1.30 (0.97–1.76) 0.08
*Adjusted for sex, birth year and number of first degree relatives. Analyses include individuals with diabetes mellitus as a contributing cause of death
doi:10.1371/journal.pone.0165026.t003
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Data were also analyzed according to cause of ESRD in first degree relatives. aHR for death
in individuals with a first degree relative with hypertensive nephropathy was 1.24 (1.14–1.34),
while aHRs for death in individuals with first degree relatives with diabetic nephropathy or
interstitial disease were 1.21 (1.13–1.29) and 1.12 (1.02–1.23) respectively(S2 Table). Interest-
ingly, aHR for death in individuals whose first degree relatives had known hereditary renal dis-
ease was slightly smaller, 1.17 (1.08–1.28) while ESRD due to glomerular disease was not
associated with an increase in aHR.
Absolute increases in mortality rates and adjusted hazard ratios between those with and
without a relative with ESRD were further explored in cohorts defined by birth year
(Table 5). These analyses showed that the absolute increases in mortality rates were highest
in cohorts born 1900–1939, which was to a large degree explained by an increase in cardio-
vascular mortality, but a significant increase in mortality due to renal diseases were also
seen. Interestingly, the cohort born 1940–1959 had a lower mortality rate if a relative had
ESRD, this was mostly explained by a lower mortality rate due to cancer. In gender specific
analyses, adjusted hazard ratios were higher for women born 1960–2009 and 1900–1919,
aHR 1.38 (1.12–1.69) and 1.15 (1.07–1.22) respectively, compared to 1.12 (1.09–1.45) and
1.05 (0.98–1.11) for men born during the same time periods. Interestingly, the highest
adjusted hazard ratio for cardiovascular death was seen in women born between 1940 and
1959, aHR 1.99 (1.46–2.67), identical analysis for men showed aHR of 1.25 (1.03–1.52) (S3
Table). Cumulative risk of death by age is also shown in Figs 3 and 4. Fig 3 shows that com-
pared to individuals without a first degree relative with ESRD, individuals with a relative
with ESRD were more likely to die at a younger age. From Fig 4 it is evident that the risk was
higher if death was due to diseases of the kidneys or ureters, cardiovascular disease or diabe-
tes mellitus.







Hazard ratio p-value Adjusted hazard
ratio*
p-value
Death due to all cause non-hereditary diseases
of the kidneys and ureters
No 5 103 092 7094 1.0 (ref)
Yes 27 508 69 2.18 (1.72–
2.77)
<0.001 2.29 (1.81–2.91) <0.001
Death due to kidney failure of uncertain
etiology
No 5 103 092 3971 1.0 (ref)
Yes 27 508 31 1.79 (1.26–
2.55)
0.001 1.80 (1.26–2.56) 0.001
Death due to glomerular disease No 5 103 092 1170 1.0 (ref)
Yes 27 508 27 4.79 (3.27–
7.01)
<0.001 5.69 (3.88–8.34) <0.001
Death due to interstitial renal disease No 5 103 092 1484 1.0 (ref)
Yes 27 508 9 1.36 (0.71–
2.62)
0.36 1.50 (0.78–2.89) 0.23
Death due to congenital or inherited renal
disease
No 5 103 092 265 1.0 (ref)
Yes 27 508 54 41.2 (30.7–
55.3)
<0.001 51.1 (37.9–68.9) <0.001
Death due to “other” renal disease No 5 103 092 469 1.0 (ref)
Yes 27 508 2 0.97 (0.24–
3.87)
0.96 1.04 (0.26–4.17) 0.96
* Adjusted for sex, birth year and number of relatives. Analyses include individuals with diabetes mellitus as a contributing cause of death.
doi:10.1371/journal.pone.0165026.t004
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Discussion
In this population of predominantly European decent, the hazard ratio for all cause death was
13% higher in individuals who had a first degree relative with ESRD as compared to individuals
who did not have a first degree relative with ESRD. The most important explanation was a
higher risk of death due to cardiovascular disease, and cerebrovascular disease was associated
with the highest hazard ratio. Hazard ratios for death due to kidney or urinary tract disease
and diabetes mellitus were also significantly increased, about two-fold. Survival curves indi-
cated that individuals with a first degree relative with ESRD were more likely to die at a
Table 5. Relative and absolute risk of death for all cause death, cardiovascular death and renal death according to whether or not a first degree
relative had ESRD and for subgroups of birth-year.
Individuals without a first degree
relative with ESRD
Individuals with a first degree relative
with ESRD
Absolute mortality increase per
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4 692 6.95 (6.76–7.15) 12
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81 581 777 (772–782) 2 064 342 710 (637–787) -67 (-142-8.1) 0.95 (0.85–1.06)
* Adjusted for sex and number of relatives. Analyses include individuals with diabetes mellitus as a contributing cause of death
doi:10.1371/journal.pone.0165026.t005
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younger age compared to individuals without a relative with ESRD, but the absolute increase in
mortality rates were highest in the oldest cohorts born 1900–1939, where an increase in mortal-
ity of 295 per 100,000 person-years was seen.
Cardiovascular disease was the most common cause of death, the aHR of 1.15 (95% CI
1.10–1.21) for cardiovascular death in individuals with a first degree relative with ESRD was
similar to the reported relative risk of 1.10 in a case control study from Utah[6]. Familial clus-
tering of cardiovascular disease[10, 11] and increased risk of cardiovascular disease with
declining GFR is well known[3, 4], diabetes mellitus is also a major risk factor for ESRD[12,
13] and known to aggregate in families[14, 15]. Analyses of different birth cohorts showed that
the hazard ratio was highest with 1.41 for the cohort born 1940–1959, the excess risk seemed to
be more pronounced in women. The incidence of smoking in Norwegian women increased
after World War II, with gender convergence in tobacco use in the mid1970s[16], which may
have impacted the risk associated with a family history of ESRD in women. The cohort born
1920–1939 had both a highly significant aHR and a highly significant increase in mortality
rates, their mean age at death was 69.5 ±10.6 years. The fairly young age at death in this cohort,
with the strongest increase in cardiovascularmortality, points towards premature cardiovascu-
lar death in individuals with a relative with ESRD. Cerebrovascular death was associated with
the highest hazard ratio in the cardiovascular category in the Norwegian population, whereas
cerebrovascular death was less common and not statistically significant in the Utah population
[6]. Acute myocardial infarction and heart failure were the two main causes of cardiovascular
death in the population from Utah. Differences in coding practices and study methodologies
could probably explain some of these differences. In the current study hypertensive or diabetic
Fig 3. Adjusted Kaplan Meier failure curve for all cause death in individuals with and without a first degree
relative with ESRD.
doi:10.1371/journal.pone.0165026.g003
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ESRD in a first degree relative were associated with a 24% and 21% increase in risk of all cause
death respectively, as compared to 13% when risk was analyzed irrespective of cause of ESRD
in first degree relatives. Some of the increased risk may be attributable to shared environmental
risk factors, or shared risk behavior such as smoking or diet. Having a relative with ESRD sig-
nificantly increased the HR for death due to cerebrovascular/cardiovascular disease and diabe-
tes mellitus, conversely hypertensive or diabetic ESRD in a first degree relative further
increased the HR for all cause death. In our opinion these consistent findings add to previous
reports, and strongly argue that shared genetic risk factors contribute to excess risk of death.
The findingsmay also account for some of the excess risk of all cause death and cardiovascular
death reported in Norwegian living kidney donors, most of whom were first degree relatives of
the recipient[7].
Adjusted hazard ratio for death from non-hereditary diseases of the kidneys and/or ureters
was 2.29 (1.81–2.91), of which aHR of death due to renal failure was 1.80 (1.26–2.56). This is
significantly lower than findings described in a registry based study from Utah[1] where first
degree relatives of ESRD patients of predominantly European decent had relative risks of dying
with ESRD or non-ESRD CKD of 10.1 and 3.89, respectively. However, risk estimates of dying
with ESRD or CKDwere given, and ESRD or CKDmay not have been the primary cause of
death. This is in contrast to our study, in which only primary causes of death were included in
the main analyses. Information on contributing causes of death was available for some, but not
all individuals. Data on chronic kidney disease as a contributing cause of death were incom-
plete, and could in our opinion not be analyzed in this study. In our study, adjusted hazard
ratio for death due to primary glomerular diseases was 5.69 (3.88–8.34) in individuals with a
Fig 4. Adjusted Kaplan Meier failure curves for different categories of death according to whether or not a
first degree relative had ESRD.
doi:10.1371/journal.pone.0165026.g004
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relative with ESRD. Disease specific causes of ESRD were not always verified by a kidney
biopsy, and some cases were likely mislabeled as non-hereditary. Current knowledge of heredi-
tary renal disease would have been unavailable for some of the follow-up period, and some
cases, such as primary focal and segmental glomerulosclerosis,may actually have been heredi-
tary[17, 18].
Somewhat unexpected, in individuals born 1940–1959, absolute cancer mortality was lower
in individuals with a relative with ESRD as compared to individuals without a relative with
ESRD. The reason for this observation is uncertain. It did not reach statistical significance in
Cox regression analyses, and may be coincidental or due to coding practices In general, studies
have shown increased risk of cancer in patients with kidney disease[19, 20] and several well-
known risk factors of kidney disease, such as hypertension, inflammation, obesity, smoking
and diet, have been shown to also be risk factors for cancer[21]. One might therefore expect an
increased risk of cancer in relatives of patients with ESRD, but to our knowledge no studies
have previously investigated this.
The strengths of this study include the nationwide cohort design and that complete national
registry data were used to ascertain risk of death. The main limitations are that data are not
complete for the whole follow-up period. Family data are complete for those born after 1952,
and ESRD was not registered until 1980. Incomplete family data before 1953 would lead to an
underestimation of the probability of having a first degree relative with ESRD, however it is
unlikely to significantly have affected the estimates of excess risk. Outcomes were not registered
until 1969, which was accounted for by the counting process modifications of the Cox regres-
sion statistics. This assumes that the effect of the predictor variable was mostly unchanged
across time, i.e. excess risk attributed to having a relative with ESRD would be similar for a
40-year-old individual in 1980 and 2005. In our opinion this assumption is fair, and unlikely to
have affected the results significantly. Adjusted hazard ratios are reported in order to eliminate
confounding variables. Incidence of ESRD increases with age, and middle aged individuals
would be more likely to have older first degree relatives with ESRD compared to younger indi-
viduals. Adjusted hazard ratios correct for older individuals beingmore likely to have a first
degree relative with ESRD at the time of death. Absolute increases in mortality rates associated
with having a first degree relative with ESRD were reported for different birth cohorts and
causes of death. The decision to illustrate the cause-specific death rates for birth cohorts and
not with traditional Kaplan Meier curves for the entire cohort was due to the fact that the dif-
ferent birth cohorts had different number of recorded relatives and different age-periods of fol-
low-up. The findings for all cause death were in the same range as the overall analyses, except
higher hazard ratios for the youngest cohort, confirming that the counting processes of Cox-
regression chosen in the main analyses were adequate. Different editions of ICD codes were
used across the follow-up period, it has not been possible to review and recode the diagnoses
indicated on the death certificates. Information on diseases not directly linked to cause of
death or disease specific risk factors were not available, and analyses could therefore not be
adjusted for i.e smoking, hypercholesterolemia or background hypertension. Of note, mortality
was only 95% at age 95 in the present study, and did not increase further, indicating a loss to
follow-up likely due to 5% emigration, which is similar to the expected number from Statistics
Norway. Emigration rate is unlikely to have affected the main results.
In conclusion, this study has quantified the excess risk of death associated with ESRD in a
first degree relative in the Norwegian population. As expected cardiovascular death and
chronic kidney disease related deaths were the main contributors to excess risk of death. Indi-
viduals who had a first degree relative with ESRD died at a younger age compared to those
without a relative with ESRD. Excess risk of death in first degree relatives of ESRD patients
may indicate shared genetic risk factors, highlighting the importance of focus on modifiable
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risk factors such as obesity, smoking, glycemic control and hypertension. Shared genetic risk
factors within families may also account for some of the increased risk of death previously
reported in Norwegian living kidney donors, most of whom were first degree relatives of the
recipient.
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